Q&A: Lundbeck’s head of R&D on letting ‘biology speak’ in neuroscience
Johan Luthman has been running R&D at Lundbeck since 2019, and part of the neuroscience leader’s remit is helping steer development of a promising but still-experimental seizure medication that the company acquired last year in ...
